Benralizumab is an interleukin-5 receptor alpha–directed cytolytic monoclonal antibody that induces direct, rapid, and substantial eosinophil depletion by means of antibody-dependent cellular ...

Benralizumab, a monoclonal antibody against the interleukin-5α receptor expressed on eosinophils, may be an option for treating EGPA. We conducted a multicenter, double-blind, phase 3 ...

The safety of benralizumab showed no “meaningful difference” compared with mepolizumab. Benralizumab only requires one monthly injection, while mepolizumab requires three. Benralizumab is ...

Benralizumab is noninferior to mepolizumab for the treatment of patients with relapsing or refractory eosinophilic granulomatosis with polyangiitis receiving standard of care. Benralizumab is ...

If you continue to have this issue please contact customerservice@slackinc.com. Patients on benralizumab had more significant change from baseline in peak gastric eosinophil counts. Persistence of ...

Benralizumab, an anti–interleukin-5 receptor alpha monoclonal antibody, was significantly better than placebo at producing a histologic response of up to six eosinophils per high-power field ...

More patients with eosinophilic esophagitis experienced a histologic response with benralizumab (Fasenra) compared with placebo, despite similar levels of continuing symptoms in the two groups at ...

Researchers conducted a real-world study to evaluate if long-term remission was viable among adult patients with SEA (mean age at the index date, 55.2 years; 58.7% women) who received benralizumab ...

These medications include benralizumab and dupilumab injections. Emphysema is a type of chronic obstructive pulmonary disease (COPD) that occurs when the air sacs in the lungs lose elasticity or ...

Find out how to take Benralizumab(drug) and its dose. Describes the best time to take the drug and precautions if any that should be followed.

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window The FDA expanded the approval of benralizumab (Fasenra) to include treatment of younger kids with uncontrolled severe ...